Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biogaia Adr Class B BIOGY

Healthcare Biotechnology
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics... see more

Recent & Breaking News (PINL:BIOGY)

US/Global Policymakers Urged to Accelerate Cancer Research, Biomedical Discovery

PR Newswire December 8, 2014

Verastem Presents Data at the 2014 American Society of Hematology Annual Meeting

Business Wire December 8, 2014

Nikon Instruments Inc. Unveils New Ti-diSPIM System at Cell Biology 2014

GlobeNewswire December 8, 2014

OpenPOWER Foundation Announces First OpenPOWER Summit

PR Newswire December 8, 2014

ADDITIONAL CLINICAL DATA FROM THE PHASE II STUDY WITH ABLYNX'S ANTI-vWF NANOBODY, CAPLACIZUMAB, PRESENTED AT THE AMERICAN SOCIETY OF HEMATOLOGY ANNUAL MEETING

GlobeNewswire December 8, 2014

Global Blood Therapeutics' GBT440 Demonstrates Ability to Positively Impact Fundamental Sickle Cell Disease (SCD) Processes in Studies Presented at 2014 American Society of Hematology (ASH) Conference

Marketwired December 8, 2014

California Healthcare Institute and Bay Area Bioscience Association Will Combine to Become the California Biomedical Innovation Alliance

Business Wire December 8, 2014

Gilead Presents Follow-up Data from Zydelig Registrational Studies in Patients with Chronic Lymphocytic Leukemia, Follicular Lymphoma and Small Lymphocytic Lymphoma

Business Wire December 8, 2014

Seattle Genetics Highlights Multiple ADCETRIS® (Brentuximab Vedotin) Data Presentations in Frontline and Salvage Hodgkin Lymphoma at ASH Annual Meeting

Business Wire December 8, 2014

Parent Project Muscular Dystrophy Awards Akashi Therapeutics, Inc. $500,000 Grant

PR Newswire December 8, 2014

Nuvilex Announces Name Change of Subsidiary to Viridis Biotech

GlobeNewswire December 8, 2014

Definiens Releases Tissue Studio® 4.0 for Quantitative Digital Pathology

Business Wire December 8, 2014

FDA Approves Amgen's XGEVA® (Denosumab) For The Treatment Of Hypercalcemia Of Malignancy Refractory To Bisphosphonate Therapy

PR Newswire December 8, 2014

Research and Markets: China Biodegradable Plastics Research and Investment Prospect Industry Report 2014

Business Wire December 8, 2014

AppDirect Named a Red Herring 100 Global Winner

Business Wire December 8, 2014

MEI Pharma Reports Significant Clinical Activity In Phase II Study Of Pracinostat In Front Line Acute Myeloid Leukemia

PR Newswire December 8, 2014

XTL Biopharmaceuticals Appoints Dr. Jonathan Schapiro MD and Dr. Dobroslav Melamed to the Board of Directors to Help Lead Development of its Clinical Assets

PR Newswire December 8, 2014

Pronutria Adds Industry Leaders to its Board of Directors

PR Newswire December 8, 2014

Research and Markets: BRIC Wound Closure Devices Market Outlook to 2020: Key players covered include Johnson & Johnson, Covidien and Baxter International

Business Wire December 8, 2014

Research and Markets: EU5 Wound Closure Devices Market Outlook to 2020: Key players covered include Johnson & Johnson, Covidien and Baxter International

Business Wire December 8, 2014